COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02860546
Recruitment Status : Completed
First Posted : August 9, 2016
Last Update Posted : September 19, 2018
Sponsor:
Information provided by (Responsible Party):
Taiho Oncology, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
Recruitment Status : Completed
Actual Primary Completion Date : November 3, 2017
Actual Study Completion Date : November 3, 2017